Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950123-01-504328
Filing Date
2001-07-13
Accepted
2001-07-13 00:00:00
Documents
3
Effectiveness Date
2001-07-13

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC. y51400s-8.txt S-8 22364
2 OPINION OF SAUL EWING LLP y51400ex5.txt EX-5 2257
3 CONSENT OF KPMG LLP y51400ex23-1.txt EX-23.1 370
  Complete submission text file 0000950123-01-504328.txt   26792
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-65072 | Film No.: 1680767
SIC: 2835 In Vitro & In Vivo Diagnostic Substances